Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hari is a medical technology company that has developed the HariComp system, an intelligent compression therapy device designed to treat chronic venous leg ulcers. The system uses integrated sensors to monitor sub-bandage pressure in real-time and automatically adjusts to maintain the prescribed therapeutic level, addressing the common issue of pressure loss in traditional bandages. By combining wearable hardware with a digital health platform, Hari aims to accelerate wound healing, improve patient adherence, and provide clinicians with remote monitoring capabilities for better management of vascular conditions. The company's technology is particularly focused on chronic venous insufficiency and lymphedema, where consistent compression is critical for successful clinical outcomes. Founded by a physician, Hari leverages data-driven insights to transform the standard of care in wound management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haricomp.